How much funding has Algen Biotechnologies raised?

Algen Biotechnologies has raised $5.4M in total funding, most recently a Venture Round.

Who are Algen Biotechnologies's investors?

Algen Biotechnologies's investors include Sequoia Capital, Cota Capital, Illumina Accelerator, Rebel Fund, Bill Tai, Viking Global.

What industry is Algen Biotechnologies in?

Algen Biotechnologies operates in Biotech.

How many employees does Algen Biotechnologies have?

Algen Biotechnologies has 11-50 employees.

Algen Biotechnologies

Biotech

Employees: 11–50
Business Model: B2B
Website: algenbio.com

Total Funding: $5.4M
Last Round: $5.4M Venture RoundNov 2024
Rounds: 3

About

Algen Biotechnologies is a therapeutic drug discovery company decoding functional gene networks to develop safer, more effective treatments for cancer and inflammatory diseases. Founded by CEO Chun-Hao Huang, PhD (formerly of Jennifer Doudna's lab at UC Berkeley) and CBO Christine Du, MBA (Wharton), the company combines CRISPR-based functional genomics, single-cell analysis, and AI-driven models to identify disease-driving RNA targets and translate them into novel small-molecule and precision therapeutics.

Summary

Algen Biotechnologies is a Biotech company. It has raised $5.4M in total across 3 rounds, most recently a $5.4M Venture Round round in Nov 2024. Investors include Sequoia Capital, Cota Capital and Illumina Accelerator.